Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Historical Holders from Q1 2023 to Q3 2025

Symbol
MRKR on Nasdaq
CUSIP
57055L206
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
16.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
3.43M
Holdings value
$3.06M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
31
Number of buys
15
Number of sells
-10
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
New Enterprise Associates 16, L.P. 9.9% -20.8% $1.7M $45.3K 1.67M +2.73% New Enterprise Associates 16, L.P. Nov 13, 2025
Alyeska Investment Group, L.P. 9.9% -0.9% $1.14M $188K 1.28M +19.8% Alyeska Investment Group, L.P. Sep 30, 2025
Blue Owl Capital Holdings LP 9.99% +96.2% $1.16M $590K 1.13M +103% Blue Owl Capital Holdings LP Mar 31, 2025

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3.43M $3.06M -$187K $0.89 31
2025 Q2 3.41M $5.22M -$775K $1.53 31
2025 Q1 4.02M $4.95M +$278K $1.23 31
2024 Q4 3.48M $10.7M +$4.73M $3.11 31
2024 Q3 1.94M $5.46M -$202K $2.82 27
2024 Q2 1.94M $10.5M +$163K $5.43 26
2024 Q1 1.91M $8.22M +$17.2K $4.30 26
2023 Q4 1.91M $10.5M +$188K $5.50 24
2023 Q3 1.87M $8.5M +$261K $4.54 26
2023 Q2 1.82M $5.66M +$1.09M $3.10 27
2023 Q1 1.62M $1.15M +$1.15M $0.71 26